Vancouver, BC -- (SBWIRE) -- 04/12/2021 -- The growth of this market can be attributed to the increasing prevalence of cancer across the globe, rise in geriatric population, and rise in adoption of radiotherapy. The technological advancement and increasing awareness among the public have led to an increase in the number of surgical operations, which in turn is augmenting the demand for the industry. Increasing technological advances in the radiotherapy is one of the factors snowballing, the market growth. For instance, Stereotactic body radiation therapy (SBRT) which differentiate between healthy cells and cancer cells and provide optimum efficacy

The Follicular Lymphoma Treatment Industry is intensely competitive and fragmented because of the presence of several established players participating in various marketing strategies to expand their market share. The vendors available in the market compete centered on price, quality, brand, product differentiation, and product portfolio. The vendors are increasingly emphasizing product customization through customer interaction.

The global Radiotherapy Market is expected to reach USD 7.65 Billion by 2027, according to a new report by Emergen Research.

You Can Download Free Sample PDF Copy of Follicular Lymphoma Treatment Market at https://www.emergenresearch.com/request-sample/51

Key highlights from the report
The North America follicular lymphoma treatment market is anticipated to dominate the global market. The growth is attributed to the rising demand for first-line therapy, high medical reimbursement facilities, and technological advancement in countries such as the U.S and Canada.
The targeted therapy is expected to register significant market share among the other segments. This is attributed to the widespread application coupled with efficient healthcare outcomes. The diagnostic methods are improved, and the public and health care professionals are well aware of the potential benefits of targeted therapy impacting the growth.
The market is driven by rapid product approval. For instance, in June 2020, The U.S. Food and Drug Administration (FDA) approved tazemetostat for relapsed or refractory follicular lymphoma (FL) for adults. The clinical pipeline also shows positive results, which would further propel the market in the near future.
The combination drug therapy is an upcoming trend in the market. For instance, in May 2019, the U.S. Food and Drug Administration (FDA) approved lenalidomide (REVLIMID) in combination with rituximab (RITUXAN) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) and marginal zone lymphoma (MZL).
Research organizations are expected to be the largest segment for the follicular lymphoma treatment market during the forecast period. The growth is contributed to its wide application in the research field. Non-Hodgkin's lymphoma is one of the most common cancers worldwide. In recent years, much research have been carried out to find the most apt therapy.

Key participants include AbbVie, Inc., Celgene, Bayer AG, Bristol Myers Squibb and Company, Epizyme Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline plc, Johnson and Johnson Services, Inc., Merck & Co. Inc., and Novartis AG.

Get access to FREE Sample PDF Copy of Follicular Lymphoma Treatment Market at https://www.emergenresearch.com/request-sample/51

Treatment Outlook (Revenue, USD million; 2017-2027)
Monoclonal Antibodies
Targeted therapy
Chemotherapy
Radiation therapy
Stem cell transplant
Alkylating Agents
Nucleoside Analogues
Anthracycline Derivatives
Others

Route of Administration Outlook (Revenue, USD million; 2017-2027)
Oral
Parenteral
Others

End Use Outlook (Revenue, USD million; 2017-2027)
Hospitals
Oncology Centers
Ambulatory Care Centers
Academic Research Institutes
Others

Key questions answered in the report
What will be the market size in terms of value and volume in the next five years?
Which segment is currently leading the market?
In which region will the market find its highest growth?
Which players will take the lead in the market?
What are the key drivers and restraints of the market's growth?

The report segments the Follicular Lymphoma Treatment market on the basis of geography, end-user, end-use, product application, type, share, growth rate and size to reveal where the industry will be in the coming years. The researchers assessing the industry have included the details about the recent decisions and events such acquisition and mergers, collaborations, product launch and investments. Important decisions connected with such events come handy for business owners when positioning their brands in the global market and finalizing the marketing strategies.

Read more@ https://www.emergenresearch.com/industry-report/follicular-lymphoma-treatment-market

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Follicular Lymphoma Treatment Market Segmentation & Impact Analysis
4.1. Follicular Lymphoma Treatment Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Stringent environmental regulations
4.2.2.2. Rising need to reduce bacterial or algal contamination in water systems
4.2.2.3. Increasing demand for biocides for municipal water treatment
4.2.3. Market restraints analysis
4.2.3.1. Fluctuating prices of raw material
4.2.3.2. Present challenging economic conditions due to the pandemic
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Follicular Lymphoma Treatment Market By Application Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. Follicular Lymphoma Treatment Market By Product type Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. Follicular Lymphoma Treatment Market Regional Outlook
Chapter 8. Competitive Landscape
Continued…